Karyopharm Therapeutics | KPTI - Zobowiązania Handlowe





Zobowiązania Handlowe Zmiana Data
AbbVie USD 3.59B 28.65B 2025-12
Abbott USD 4.24B 117M 2025-12
Amgen USD 19.52B 1.37B 2026-03
AstraZeneca USD 22.51B 2.78B 2026-03
BioCryst Pharmaceuticals USD 10.96M 4.87M 2026-03
Bristol-Myers Squibb USD 4.23B 659M 2026-03
Eli Lilly USD 5.03B 350M 2026-03
Enanta Pharmaceuticals USD 1.88M 63K 2025-12
GlaxoSmithKline GBP 14.34B 1.05B 2026-03
Incyte USD 228.62M 1.41B 2026-03
J&J USD 10.46B 1.53B 2026-03
Karyopharm Therapeutics USD 4M 1.39M 2025-12
MacroGenics USD 4.29M 500K 2026-03
Merck USD 3.86B 541M 2026-03
Nektar Therapeutics USD 10.77M 4.79M 2025-12
Novartis USD 4.32B 134M 2026-03
Novartis USD 4.46B 99M 2025-12
Pfizer USD 4.51B 734M 2026-03
Regeneron Pharmaceuticals USD 1.03B 4.81B 2026-03
Roche Holding CHF 5.78B 1.27B 2025-12
Sangamo BioSciences USD 10.74M 7.46M 2025-06
Takeda JPY 491.34B 23.75B 2026-03
Tectonic Therapeutic USD 2.55M 1.46M 2026-03
TG Therapeutics USD 148.84M 41.34M 2026-03
Ultragenyx Pharmaceutical USD 42M 11M 2026-03
Xencor USD 7.92M 2.91M 2026-03